- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1745-6215
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Noninferiority trials ; volume:1 ; number:1 ; day:31 ; month:7 ; year:2000 ; pages:1-3 ; date:4.2000
Trials ; 1, Heft 1 (31.7.2000), 1-3, 4.2000
- Urheber
-
Snapinn, Steven M.
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1186/cvm-1-1-019
- URN
-
urn:nbn:de:1111-2016050214471
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
- 14.08.2025, 10:59 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Snapinn, Steven M.
- SpringerLink (Online service)
Ähnliche Objekte (12)
Analyzing noninferiority trials: it is time for advantage deficit assessment – an observational study of published noninferiority trials
Interpreting the results of noninferiority trials—a review
Understanding the null hypothesis (H0) in non-inferiority trials
Evidence-based sizing of non-inferiority trials using decision models
Phase IV non-inferiority trials and additional claims of benefit
Is there a danger of “biocreep” with non-inferiority trials?
Maximum likelihood theory for retention of effect non-inferiority trials
Planning and analysis of two- and three-arm non-inferiority trials
The use of randomisation-based efficacy estimators in non-inferiority trials
Response to: Understanding the null hypothesis (H0) in non-inferiority trials
Handling an uncertain control group event risk in non-inferiority trials: non-inferiority frontiers and the power-stabilising transformation
Short postsurgical antibiotic therapy for spinal infections: protocol of prospective, randomized, unblinded, noninferiority trials (SASI trials)
Analyzing noninferiority trials: it is time for advantage deficit assessment – an observational study of published noninferiority trials
Interpreting the results of noninferiority trials—a review
Understanding the null hypothesis (H0) in non-inferiority trials
Evidence-based sizing of non-inferiority trials using decision models
Phase IV non-inferiority trials and additional claims of benefit
Is there a danger of “biocreep” with non-inferiority trials?
Maximum likelihood theory for retention of effect non-inferiority trials
Planning and analysis of two- and three-arm non-inferiority trials
The use of randomisation-based efficacy estimators in non-inferiority trials
Response to: Understanding the null hypothesis (H0) in non-inferiority trials
Handling an uncertain control group event risk in non-inferiority trials: non-inferiority frontiers and the power-stabilising transformation
Short postsurgical antibiotic therapy for spinal infections: protocol of prospective, randomized, unblinded, noninferiority trials (SASI trials)
Analyzing noninferiority trials: it is time for advantage deficit assessment – an observational study of published noninferiority trials
Interpreting the results of noninferiority trials—a review
Understanding the null hypothesis (H0) in non-inferiority trials
Evidence-based sizing of non-inferiority trials using decision models
Phase IV non-inferiority trials and additional claims of benefit
Is there a danger of “biocreep” with non-inferiority trials?
Maximum likelihood theory for retention of effect non-inferiority trials
Planning and analysis of two- and three-arm non-inferiority trials
The use of randomisation-based efficacy estimators in non-inferiority trials
Response to: Understanding the null hypothesis (H0) in non-inferiority trials
Handling an uncertain control group event risk in non-inferiority trials: non-inferiority frontiers and the power-stabilising transformation